Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRACTSystemic lupus erythmatosus (SLE) is an autoimmune disease which involved many organs. One of its severe manifestations is lupus nephritis (LN). Treatment of LN consist of two phases, induction and maintenance. Inappropriate treatmen approach could increase morbidity and mortality in LN pantients. Renal flare is among many bad outcomes of LN that should be mitigated with an approciate therapuitec approach. Various guidelines stated usage of mycophenolate mofetil (MMF) or azathioprine (AZA) as an appropriate immunosuppresant in the maintenence phase"

"ABSTRAKSalmonella as a causative agent in septic bursitis is considered rare. We report a case of 56 years old male with history of renal transplantation and using mycophenolate mofetil, cyclosporine and methylprednisolone as maintenance, admitted due to 3 week fever associated with tenderness and swelling on left shoulder. Upon investigation, a diagnosis of septic bursitis was established. Salmonella enteritidis as the definitive causative agent was revealed. He was treated with meropenem 1g IV three times daily and levofloxacin 500 mg IV once a day for 3 weeks, followed by oral ciprofloxacin 500 mg twice a day for 2 weeks and oral metronidazole 500 mg three times a day for 1 week with a total duration of 5 weeks of antibiotics. On the subsequent follow up there was no recurrence episode of fever and the swelling of the left shoulder subsided, no tenderness noted and the patient has no limitation of range of movement. Since immunocompromised state complicates the management, the duration of therapy may twice longer than the typical management of septic bursitis. Salmonella as etiologic agent should be considered as differential in immunocompromised patient with septic bursitis."

"ABSTRAKSalmonella as a causative agent in septic bursitis is considered rare. We report a case of 56 years old male with history of renal transplantation and using mycophenolate mofetil, cyclosporine and methylprednisolone as maintenance, admitted due to 3 week fever associated with tenderness and swelling on left shoulder. Upon investigation, a diagnosis of septic bursitis was established. Salmonella enteritidis as the definitive causative agent was revealed. He was treated with meropenem 1g IV three times daily and levofloxacin 500 mg IV once a day for 3 weeks, followed by oral ciprofloxacin 500 mg twice a day for 2 weeks and oral metronidazole 500 mg three times a day for 1 week with a total duration of 5 weeks of antibiotics. On the subsequent follow up there was no recurrence episode of fever and the swelling of the left shoulder subsided, no tenderness noted and the patient has no limitation of range of movement. Since immunocompromised state complicates the management, the duration of therapy may twice longer than the typical management of septic bursitis. Salmonella as etiologic agent should be considered as differential in immunocompromised patient with septic bursitis."

"ABSTRAKZirkonium sebagai biomaterial logam mulai banyak diteliti dalam beberapa tahun ini. Sifat mekanis, biokompatibilitas, dan magnetic suscetibility yang baik menjadi pertimbangan digunakan zirkonium untuk aplikasi biomaterial. Namun demikian paduan zirkonium masih memiliki beberapa kekurangan sehingga dilakukan penelitian untuk mendapatkan sifat yang optimal dari paduan zirkonium. Pengaruh temperatur dan waktu sebagai parameter sinter untuk paduan Zr-8Mo-4Nb untuk aplikasi biomaterial menggunakan metalurgi serbuk telah diamati dalam penelitian ini. Densitas dan Porositas paduan telah diukur menggunakan Prinsip Archimedes. Mikrostuktur paduan diuji menggunakan X-Ray diffractometer (XRD), Secondary Electron Microscope (SEM), dan Mikroskop Optik (OM), kekerasan paduan juga diukur menggunakan Rockwell C, dan bioaktifitas menggunakan larutan SBF dilanjutkan dengan FTIR. Hasil penelitian menunjukan dengan peningkatan temperatur dan waktu tahan sinter, akan meningkatkan densitas, kekerasan serta menurunkan porositas paduan Zr-8Mo-4Nb. Selain itu paduan Zr-8Mo-4Nb juga memiliki sifat bioaktivitas yang baik dengan membentuk lapisan hidroksiapatit pada permukaan sampel

---

ABSTRACTZirconium as biomaterial has been widely researched in recent years. Mechanical properties, biocompatibility, and magnetic suscetibility well into consideration use zirconium for biomaterial applications. However, zirconium alloy still have some disadvantages, and the purpoes of this research to get the optimal properties of zirconium alloy. Effect of sintering temperature and holding time of Zr-4Nb-8Mo alloy for biomaterials application using powder metallurgy has been observed in this study. Density and porosity are measured using Archimedes principles. The microstructure was evaluated with X-Ray diffractometer (XRD), Secondary Electrone Microscope (SEM) and Optical Microscope (OM), hardness was measured with Rockwell C hardness. Bioactivity was tested with SBF solution continued with FTIR. The results showed that increasing sintering temperature and holding time will increase the density, hardness and reducce the porosity of Zr-4Nb-8Mo alloys. Furthermore Zr-8Mo-4Nb showed a good bioactivity indicated by hydroxyapatite formation on the surface."

"Latar Belakang: Tujuan studi ini adalah membandingkan terapi antara siklofosfamid dan mikofenolat mofetil pada remisi nefritis lupus melalui sebuah laporan kasus berbasis bukti (evidence-based case report) yang diperoleh dari telaah sistematis dan meta-analisis.Metode: Metode yang digunakan pada studi ini adalah laporan kasus berbasis bukti menggunakan telaah sistematis dan meta-analisis. Pertanyaan klinis adalah manakah terapi imunosupresan yang memberikan hasil lebih baik pada remisi nefritis lupus; siklofosfamid atau mikofenolat mofetil? Untuk menjawab pertanyaan tersebut, kami melakukan pencarian dari situs PubMed dengan kata kunci ?lupus nephritis AND mycophenolate mofetil AND cyclophosphamide? dengan batasan telaah sistematis dan/atau meta-analisis, bahasa Inggris, dan hanya melakukan perbandingan secara spesifik terhadap kedua obat.Hasil: Dari pencarian awal, kami memperoleh 11 artikel telaah sistematis dan/atau meta-analisis terkait terapi nefritis lupus. Satu artikel dieksklusi karena berbahasa Yahudi, empat artikel lain dieksklusi karena tidak spesifik melakukan perbandingan terhadap mikofenolat mofetil dan siklofosfamid sehingga diperoleh enam studi yang ikut serta dalam telaah kritis dan diskusi laporan kasus kami.Kesimpulan: Berdasarkan bukti-bukti ilmiah yang diperoleh, mikofenolat mofetil memberikan efektivitas yang sama (non-inferior) dengan siklofosfamid dalam mencapai remisi pada nefritis lupus, tetapi memiliki tingkat keamanan yang lebih baik daripada siklofosfamid. Pasien pada kasus mendapatkan mikofenolat mofetil dan telah menunjukkan perbaikan secara klinis ke arah remisi pada evaluasi pasca-rawat inap

---

Background: The aim of this case study is to compare the effectiveness between cyclophosphamide and mycophenolate mofetil to achieve remission of lupus nephritis in an evidence-based case report from meta-analyses.

Methods: Method in this case study is evidence-based case report using meta-analyses. Clinical question used in this paper is; which immunosuppressant gives better result in achieving remission in lupus nephritis patient: cyclophosphamide or mycophenolate mofetil? To answer this question, we search the evidence from PubMed with the keywords: ?lupus nephritis AND mycophenolate mofetil AND cyclophosphamide? with inclusion criteria of meta-analysis, written in English, and focused comparing cyclophosphamide and mycophenolate mofetil.

Results: From the searching method, we found 11 articles which is relevant. One has been excluded since it written in Hebrew, 4 articles excluded since are not focus answering the clinical question. At the end, 6 studies were included to the critical appraisal step.

Conclusion: Based on the evidences, mycophenolate mofetil is non-inferior to cyclophosphamide in achieving remission in lupus nephritis patients, but with the better safety profile. Patient in our case study get mycophenolate mofetil and shows better clinical condition towards remission as she are evaluated in the outpatient clinic."